BioTech MLSS

Milestone Completes Debt-To-Equity Conversion With Board Members At $0.50 Per Share

(RTTNews) - Milestone Scientific Inc. (MLSS), a technology-focused medical research and development company, announced on Wednesday the elimination of its debt by converting all outstanding loans into common stock.

Three members of the company's Board of Directors reportedly carried out the debt-to-equity conversion of $465,000 into 976,870 shares of common stock, at the price of $0.50 per share.

The issuance of shares to the directors was completed on August 19, 2026.

With the elimination of outstanding notes payable, Milestone is now in possession of a debt-free balance sheet.

MLSS is currently trading at $0.49, up 2.87%.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available